Crossmark

Early administration of selected CD34 peripheral blood stem cell following bone marrow transplantation to prevent graft rejection: experience in haploidentical transplant for sickle cell disease

Crossref DOI link: https://doi.org/10.1038/s41409-025-02685-0

Published Online: 2025-09-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Barthélemy, Clara. https://orcid.org/0000-0003-4658-6169
Jestin, Matthieu

Brignier, Anne

Parquet, Nathalie

Chevillon, Florian

Boissel, Nicolas https://orcid.org/0000-0003-2091-7927
Nasone, Justine https://orcid.org/0000-0002-3614-8344
Peffault de Latour, Régis

Faivre, Lionnel https://orcid.org/0000-0002-4353-127X
Dhédin, Nathalie https://orcid.org/0009-0003-3085-6539
License Information

Text and Data Mining valid from 2025-09-12

Version of Record valid from 2025-09-12
More Information

Article History

Received: 10 April 2025

Revised: 12 June 2025

Accepted: 10 July 2025

First Online: 12 September 2025

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below